miR-191-5p suppresses PRRSV replication by targeting porcine EGFR to enhance interferon signaling

被引:0
|
作者
Pan, Yu [1 ]
Zhang, Lin [1 ]
Ma, Wenjie [1 ]
Ibrahim, Yassein M. [2 ]
Zhang, Wenli [1 ]
Wang, Mengjie [1 ]
Wang, Xinrong [3 ]
Xu, Yunfei [1 ]
Gao, Caixia [1 ]
Chen, Hongyan [1 ]
Zhang, He [1 ]
Xia, Changyou [1 ]
Wang, Yue [1 ,2 ,3 ]
机构
[1] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Anim Dis Control & Prevent, Heilongjiang Prov Key Lab Lab Anim & Comparat Med, Harbin, Peoples R China
[2] Chongqing Acad Anim Sci, Natl Ctr Technol Innovat Pigs, Chongqing, Peoples R China
[3] Southwest Univ, Coll Vet Med, Chongqing, Peoples R China
关键词
porcine reproductive and respiratory syndrome virus; miR-191-5p; porcine epidermal growth factor receptor; signal transducer and activator of transcription 3; IFN-I; RESPIRATORY SYNDROME VIRUS; INFLUENZA-A VIRUS; MICRORNA; RNA; IDENTIFICATION; EXPRESSION; RESISTANCE; INFECTION; PATHWAY; PROTEIN;
D O I
10.3389/fmicb.2024.1473504
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major thread to the global swine industry, lack of effective control strategies. This study explores the regulatory role of a small non-coding RNA, miR-191-5p, in PRRSV infection. We observed that miR-191-5p significantly inhibits PRRSV in porcine alveolar macrophages (PAMs), contrasting with negligible effects in MARC-145 and HEK293-CD163 cells, suggesting a cell-specific antiviral effect. Further investigation unveiled that miR-191-5p directly targets the porcine epidermal growth factor receptor (EGFR), whose overexpression or EGF-induced activation suppresses type I interferon (IFN-I) signaling, promoting PRRSV replication. In contrast, siRNA-or miR-191-5p-induced EGFR downregulation or EGFR inhibitor boosts IFN-I signaling, reducing viral replication. Notably, this miRNA alleviates the suppressive effect of EGF on IFN-I signaling, underscoring its regulatory function. Further investigation revealed interconnections among miR-191-5p, EGFR and signal transducer and activator of transcription 3 (STAT3). Modulation of STAT3 activity influenced IFN-I signaling and PRRSV replication, with STAT3 knockdown countering EGFR activation-induced virus replication. Combination inhibition of STAT3 and miR-191-5p suggests that STAT3 acts downstream in EGFR's antiviral response. Furthermore, miR-191-5p's broad efficacy in restricting various PRRSV strains in PAMs was identified. Collectively, these findings elucidate a novel mechanism of miR-191-5p in activating host IFN-I signaling to inhibit PRRSV replication, highlighting its potential in therapeutic applications against PRRSV.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients
    Vistbakka, J.
    Sumelahti, M. -L.
    Lehtimaki, T.
    Elovaara, I.
    Hagman, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (02): : 130 - 136
  • [22] Circulating miR-191-5p, miR-223-3p, miR-24-3p and miR-128-3p in sera of MS patients, longitudinal study
    Vistbakka, I.
    Raitoharju, E.
    Elovaara, I.
    Sumelahti, M. -L.
    Lehtimaki, T.
    Hagman, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 283 - 283
  • [23] Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients
    Berillo, Olga
    Huo, Ku-Geng
    Fraulob-Aquino, Julio C.
    Richer, Chantal
    Briet, Marie
    Boutouyrie, Pierre
    Lipman, Mark L.
    Sinnett, Daniel
    Paradis, Pierre
    Schiffrin, Ernesto L.
    AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (06) : 505 - 513
  • [24] MiR-191-5p inhibits KLF6 to promote epithelial-mesenchymal transition in breast cancer
    Pan, Ling
    Liu, Wenya
    Zhao, Hao
    Chen, Bin
    Yue, Xuandi
    TECHNOLOGY AND HEALTH CARE, 2023, 31 (06) : 2251 - 2265
  • [25] Clinical value of miR-191-5p in predicting the neurological outcome after out-of-hospital cardiac arrest
    Jie Yu
    Aihua Zhou
    Ying Li
    Irish Journal of Medical Science (1971 -), 2022, 191 : 1607 - 1612
  • [26] MicroRNA gga-miR-455-5p suppresses Newcastle disease virus replication via targeting cellular suppressors of cytokine signaling 3
    Wang, Xiangwei
    Jia, Yanqing
    Ren, Juan
    Liu, Haijin
    Xiao, Sa
    Wang, Xinglong
    Yang, Zengqi
    VETERINARY MICROBIOLOGY, 2019, 239
  • [27] Mir-331-3p Inhibits PRRSV-2 Replication and Lung Injury by Targeting PRRSV-2 ORF1b and Porcine TNF-α
    You, Xiangbin
    Qu, Yilin
    Zhang, Yue
    Huang, Jingshu
    Gao, Xiaoxiao
    Huang, Chengyu
    Luo, Gan
    Liu, Qian
    Liu, Min
    Xu, Dequan
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [28] EPIGENETIC SIGNATURE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER: IDENTIFICATION OF MIR-23A-5P, MIR-26B-5P, MIR-185-5P AND MIR-191-5P AS A POTENTIAL BIOMARKER IN PERIPHERAL BLOOD MONONUCLEAR CELLS
    Sanchez-Mora, Cristina
    Soler Artigas, Maria
    Garcia-Martinez, Iris
    Pagerols, Mireia
    Rovira, Paula
    Corrales, Montse
    Fadeuilhe, Christian
    Padilla, Natalia
    de la Cruz, Xavier
    Frankex, Barbara
    Arias-Vasquez, Alejandro
    Casas, Miguel
    Ramos-Quiroga, Josep-Antoni
    Ribases, Marta
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1112 - 1112
  • [29] Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells
    Sanchez-Mora, Cristina
    Soler Artigas, Maria
    Garcia-Martinez, Iris
    Pagerols, Mireia
    Rovira, Paula
    Richarte, Vanesa
    Corrales, Montse
    Fadeuilhe, Christian
    Padilla, Natalia
    de la Cruz, Xavier
    Franke, Barbara
    Arias-Vasquez, Alejandro
    Casas, Miguel
    Ramos-Quiroga, Josep-Antoni
    Ribases, Marta
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (05) : 890 - 897
  • [30] Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma
    Chen, Xiao-Yu
    Zhang, Jing
    Hou, Li-Dan
    Zhang, Rui
    Chen, Wei
    Fan, Hui-Ning
    Huang, Yan-Xia
    Liu, Hui
    Zhu, Jin-Shui
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2018, 32 : 1 - 15